Abstract
There is no evidence that disease modifying therapies (DMTs) are beneficial in progressive (non-relapsing) MS. However, these patients may benefit from multidiscipliniary interventions, and require financial and community support. Non-pharmacological needs of MS patients may be overlooked during fund allocation, and identification of unmet needs is important to optimise care and inform governmental resource distribution. To identify unmet needs of MS patients in 3 areas during an Irish epidemiology study. Observational study in 3 regions in Ireland: South Dublin SCD (an urban area), Donegal DGL and Wexford WEX (rural counties).A validated Needs Assessment Questionnaire (NAQ) was completed by MS patients at research clinics, or by telephone if unable to attend. We identified 632 patients with multiple sclerosis: 23% SCD (urban), 30.8% WEX, and 46.2% DGL.MS subtype was relapsing remitting (RR) in 51.1%, secondary progressive (SP) in 39.7%, and primary progressive (PP) in 9.2%. EDSS was </=6 in 86% and >6.5 in 14%. NAQ was completed by 325 (49.9%).Group A: 155 (47.7%) reported no unmet needs relating to MS.Group B: 170 (52.3%) reported unmet needs relating to MS,including all in a group continuing to use disease-modifying therapy ...Continue Reading
References
Nov 1, 1983·Neurology·J F Kurtzke
Jan 9, 1993·BMJ : British Medical Journal·M H Williams, C Bowie
Apr 1, 1996·Neurology·F D Lublin, S C Reingold
May 31, 1997·BMJ : British Medical Journal·P M RothwellP J Dorman
Aug 1, 1997·Annals of Neurology·J A FreemanA J Thompson
Jan 28, 1999·Neurology·A SolariL Mendozzi
Jul 10, 1999·Social Science & Medicine·C E Schwartz, M A Sprangers
Feb 25, 2000·Clinical Rehabilitation·S J Smith, C A Young
Nov 18, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·J A Freeman, A J Thompson
Dec 29, 2000·Clinical Rehabilitation·P KerstenJ A Smith
Feb 13, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·C M WilesA Morgan
Nov 12, 2005·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Mar 31, 2007·Journal of Advanced Nursing·Angus ForbesMelissa Taylor
Jul 7, 2007·Multiple Sclerosis : Clinical and Laboratory Research·F PattiUNKNOWN Italian Study Group On Quality Of Life In Ms
Jul 26, 2008·Multiple Sclerosis : Clinical and Laboratory Research·R VazirinejadC Ward
Dec 17, 2009·Multiple Sclerosis : Clinical and Laboratory Research·Claudia Christina Hilt PflegerNils Koch-Henriksen
Jan 21, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·R LonerganN Tubridy
Citations
Sep 28, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Arie GafsonPaul M Matthews
Dec 23, 2017·International Journal of MS Care·Evan CampbellLorna Paul
Jun 30, 2018·Disability and Rehabilitation·Afolasade FakoladeMarcia Finlayson
Feb 28, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Michela PonzioMichele Messmer Uccelli
Oct 24, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Per Soelberg SorensenGiancarlo Comi
Nov 27, 2019·Neurodegenerative Disease Management·Jiwon OhCatherine Larochelle
Nov 13, 2020·International Journal of MS Care·Jocelyn MarrowDebra Frankel
Aug 7, 2021·Journal of Personalized Medicine·Alessandra BujaGianfranco Damiani